Clinical Trials
5 trialsNCT03493646 2024-05-28
Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486
Kirby Institute
Phase 2 Completed
NCT06256627 2024-02-13
The Maintenance Treatment of "ITIVA" in AML Patients
Henan Cancer Hospital
Phase NA Recruiting
NCT06105658 2023-10-30
Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML
Anhui Provincial Hospital
Phase 2 Unknown
NCT02275663 2015-01-06
Azacytidine Plus FLAG for Relapsed or Refractory AML
King Fahad Medical City
Phase 2 Unknown
NCT00412919 2013-12-16
Study of Azacitidine to Treat Relapsed or Refractory Multiple Myeloma
Bayside Health
Phase 2 Terminated